HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

type 3 Bartter syndrome

Also Known As:

Bartter syndrome, type 3; Bartter syndrome, classic

Networked: 8 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Related Diseases

1.	Acute Kidney Injury (Acute Renal Failure)
2.	Bartter Syndrome (Syndrome, Bartter)

Experts

1.	Teulon, Jacques: 4 articles (08/2017 - 09/2014)
2.	Andrini, Olga: 3 articles (08/2017 - 09/2014)
3.	Keck, Mathilde: 3 articles (08/2017 - 09/2014)
4.	Vargas-Poussou, Rosa: 3 articles (08/2017 - 09/2014)
5.	Blanchard, Anne: 2 articles (08/2017 - 09/2014)
6.	Mansour-Hendili, Lamisse: 2 articles (08/2017 - 09/2014)
7.	Iijima, Kazumoto: 2 articles (12/2016 - 01/2014)
8.	Briones, Rodolfo: 2 articles (06/2015 - 09/2014)
9.	Lourdel, Stéphane: 2 articles (06/2015 - 09/2014)
10.	Li, Qiu: 1 article (01/2018)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to type 3 Bartter syndrome:

1.	Chloride Channels (Chloride Channel)IBA 01/01/2023 - "Bartter syndrome type 3 (BS 3) is a monogenic tubulopathy caused by deleterious variants in the chloride channel gene CLCNKB, a high proportion of these being large gene deletions. " 06/15/2015 - "ClC-K chloride channels: emerging pathophysiology of Bartter syndrome type 3." 06/15/2015 - "The mutations in the CLCNKB gene encoding the ClC-Kb chloride channel are responsible for Bartter syndrome type 3, one of the four variants of Bartter syndrome in the genetically based nomenclature. " 08/01/2017 - "Bartter syndrome type 3 is a clinically heterogeneous hereditary salt-losing tubulopathy caused by mutations of the chloride voltage-gated channel Kb gene (CLCNKB), which encodes the ClC-Kb chloride channel involved in NaCl reabsorption in the renal tubule. "
2.	SaltsIBA 09/01/2014 - "CLCNKB mutations cause Bartter syndrome type 3, a hereditary renal salt-wasting tubulopathy. " 08/01/2017 - "Bartter syndrome type 3 is a clinically heterogeneous hereditary salt-losing tubulopathy caused by mutations of the chloride voltage-gated channel Kb gene (CLCNKB), which encodes the ClC-Kb chloride channel involved in NaCl reabsorption in the renal tubule. "
3.	ChloridesIBA 01/01/2017 - "We combined in silico and in vitro techniques to analyze amino acids involved in the chloride ion pathway as well as to rationalize the possible role of several clinically observed mutations leading to the Bartter syndrome type 3. Virtual screening and drug repositioning computations were then carried out. " 01/01/2017 - "The human ClC-Kb channel plays a key role in exporting chloride ions from the cytosol and is known to be involved in Bartter syndrome type 3 when its permeation capacity is decreased. " 08/01/2017 - "Bartter syndrome type 3 is a clinically heterogeneous hereditary salt-losing tubulopathy caused by mutations of the chloride voltage-gated channel Kb gene (CLCNKB), which encodes the ClC-Kb chloride channel involved in NaCl reabsorption in the renal tubule. "
4.	IonsIBA 01/01/2017 - "The human ClC-Kb channel plays a key role in exporting chloride ions from the cytosol and is known to be involved in Bartter syndrome type 3 when its permeation capacity is decreased. "
5.	Ibuprofen (Motrin)FDA LinkGeneric 01/01/2018 - "Bartter Syndrome Type 3: Phenotype-Genotype Correlation and Favorable Response to Ibuprofen."
6.	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/01/2016 - "Acute kidney injury in type 3 Bartter syndrome: Angiotensin-converting enzyme inhibitors as a cause."
7.	Amino Acids FDA Link 01/01/2017 - "We combined in silico and in vitro techniques to analyze amino acids involved in the chloride ion pathway as well as to rationalize the possible role of several clinically observed mutations leading to the Bartter syndrome type 3. Virtual screening and drug repositioning computations were then carried out. "
8.	Adrenocorticotropic Hormone (ACTH)FDA Link 01/01/2014 - "Bartter syndrome type 3 in an elderly complicated with adrenocorticotropin-deficiency."